| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/24/1997 | US5641797 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[cd] indoles |
| 06/24/1997 | US5641796 Oral hypoglycemic agents |
| 06/24/1997 | US5641794 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[cd]indoles |
| 06/24/1997 | US5641793 Pyridine compounds which have useful pharmaceutical activity |
| 06/24/1997 | US5641792 Benzoylguanidines substituted by heterocyclic N-oxide, process for their preparation and pharmaceutical compositions containing them |
| 06/24/1997 | US5641790 Pharmaceutical formulation in low dosage unit form containing 2-phenyl-3-aroylbenzothiophene derivative |
| 06/24/1997 | US5641789 Sulfonamide derivatives of benzenefused hydroxy substituted cycloalkyl and heterocyclic ring compounds |
| 06/24/1997 | US5641787 Indole derivatives as dopamine D4 antagonists |
| 06/24/1997 | US5641786 Quinuclidine derivatives |
| 06/24/1997 | US5641785 Antidepressants, nervous system disorders |
| 06/24/1997 | US5641783 Antiinflammatory or immunosuppressive agents |
| 06/24/1997 | US5641781 Topical ophthalmic composition comprising a 2-[4-(azolylbutyl)piperazinylmethyl]benzimidazole derivative, in particular for the treatment of allergic conjunctivitis |
| 06/24/1997 | US5641779 Selective ligands of 5-HT1D -5-HT1B receptors derived from indolepiperazine which are useful medicaments |
| 06/24/1997 | US5641778 Aromatically substituted ω-amino-alkanoic acid amides and alkanoic acid diamides |
| 06/24/1997 | US5641777 Neurokinin receptor antagonist |
| 06/24/1997 | US5641776 Treating rheumatoid diseases |
| 06/24/1997 | US5641775 3-phenylureido-1,5-benzodiazepine-diones useful as gastrin or antagonists |
| 06/24/1997 | US5641774 Compounds useful as antiproliferative agents and garft inhibitors |
| 06/24/1997 | US5641773 Methods for treating viral infections |
| 06/24/1997 | US5641772 Condensed diazepinones, processes for preparing them and agents containing these compounds for treating diseases of the central nervous system and for promoting cerebral blood circulation |
| 06/24/1997 | US5641771 Compounds useful as antiproliferative agents and garft inhibitors |
| 06/24/1997 | US5641770 Thienamycins antibiotics |
| 06/24/1997 | US5641769 treatment for toxoplasmoisis with a composition containing a hydroxynaphthoquinone and a spiropiperidyl derivative of rifamycin S. |
| 06/24/1997 | US5641768 Preventing cells from adhering to one another; regulating immune response |
| 06/24/1997 | US5641767 Modified bile acids process for their preparation and their use |
| 06/24/1997 | US5641766 Stimulation of antibody response in depressed mammalian immune systems by administering c-7 substituted 5-androstene-3-ol-17-one |
| 06/24/1997 | US5641763 N-phosphonylmethoxyalkyl derivatives of pyrimdine and purine bases and a therapeutical composition therefrom with antiviral activity |
| 06/24/1997 | US5641762 Treating degenerative bone disorders by administering compound formed by reacting bridging agent with carbonic anhydrase inhibitor, then with bone seeking agent |
| 06/24/1997 | US5641761 Feeding crustacea food containing water-soluble schizophyllan and mycelia of schizophyllan-producing fungus |
| 06/24/1997 | US5641760 Method of treating candida infection |
| 06/24/1997 | US5641757 Stable 2-chloro-2'-deoxyadenosine formulations |
| 06/24/1997 | US5641756 Synthetic oligonucleotide complementary to nucleic acid specific for human vascular endothelial growth factor |
| 06/24/1997 | US5641755 Administering to mammal a lipoxygenase inhibitor; delivering to tumor a dna molecule comprising a radiation inducible promoter operatively linked to a region encoding a tumor inhibiting polypeptide |
| 06/24/1997 | US5641750 Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product |
| 06/24/1997 | US5641749 Method for treating retinal ganglion cell injury using glial cell line-derived neurothrophic factor (GDNF) protein product |
| 06/24/1997 | US5641670 Protein production and protein delivery |
| 06/24/1997 | US5641665 Plasmids suitable for IL-2 expression |
| 06/24/1997 | US5641662 Transfection of lung via aerosolized transgene delivery |
| 06/24/1997 | US5641657 DNA encoding an interleukin-6 splice variant |
| 06/24/1997 | US5641636 Method of predicting fetal membrane rupture based on matrix metalloproteinase-9 activity |
| 06/24/1997 | US5641625 Peptide nucleic acids forming duplex, triplex and other structures with nucleic acids; modulation of protein activity by transcription arrest and initiation; specific site cleavage |
| 06/24/1997 | US5641519 Method of treating endotoxic shock employing gallium compounds |
| 06/24/1997 | US5641514 Comprising antibiotic mixed powder consisting of ticarcillin, cafazolin, tobramycin, vancomycin, polymethyl methacrylate powder cement, methyl methacrylate liquid cement |
| 06/24/1997 | US5641512 Shell contains xanthine derivative |
| 06/24/1997 | US5641500 Administering analog of purine nucleotide |
| 06/24/1997 | US5641476 Antiperspirant, dihydroxy fatty acid gel, oils, solvents |
| 06/24/1997 | US5641475 Antiodor, antimicrobial and preservative compositions and methods of using same |
| 06/24/1997 | CA2010054C Method of weight control by low level administration of cobalt protoporphyrin or cobalt mesoporphyrin |
| 06/23/1997 | CA2193171A1 Thiazolidinedione derivatives, method for preparing the derivatives and pharmaceutical compositions containing same |
| 06/22/1997 | CA2193610A1 17 .alpha.-cyanomethylestra-4, 9-dien derivative compounds, processes for making same and pharmaceutical compositions containing same |
| 06/22/1997 | CA2193308A1 New thiophene compounds; process for preparing the same and pharmaceutical compositions containing them |
| 06/19/1997 | WO1997021993A2 Nuclear receptor ligands and ligand binding domains |
| 06/19/1997 | WO1997021826A2 Complementary adenoviral vector systems and cell lines |
| 06/19/1997 | WO1997021820A2 A novel protein kinase required for ras signal transduction |
| 06/19/1997 | WO1997021819A1 Novel nagpu |
| 06/19/1997 | WO1997021815A2 Antifungal proteins |
| 06/19/1997 | WO1997021814A1 Antifungal proteins |
| 06/19/1997 | WO1997021811A2 Novel tyrosine kinase receptors and ligands |
| 06/19/1997 | WO1997021808A1 Modified vegf antisense oligonucleotides |
| 06/19/1997 | WO1997021801A2 Production and screening process for phytochemical production by plant cell cultures |
| 06/19/1997 | WO1997021744A1 Copolymers of carboxylic acids and multiply olefinically unsaturated carboxylic acid derivatives and their use as thickeners and dispergents |
| 06/19/1997 | WO1997021731A1 Assay for and uses of peptide hormone receptor ligands |
| 06/19/1997 | WO1997021726A1 Agents for promoting bone formation |
| 06/19/1997 | WO1997021725A1 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties |
| 06/19/1997 | WO1997021724A1 Steroid nitrite ester derivatives useful as anti-inflammatory drugs |
| 06/19/1997 | WO1997021721A1 Novel steroid nitrite/nitrate ester derivatives useful as anti-inflammatory drugs |
| 06/19/1997 | WO1997021720A2 Processes for preparation of 7 alpha-carboxyl 9,11-epoxy steroids and intermediates useful therein and a general process for the epoxidation of olifinic double bonds |
| 06/19/1997 | WO1997021716A1 NAPHTHYL GLYOXAMIDES AS sPLA2 INHIBITORS |
| 06/19/1997 | WO1997021712A1 Carbapenem-3-carboxylic acid ester derivatives |
| 06/19/1997 | WO1997021710A1 Use of heteroaromatic and tricyclic 1,4-dihydro-1,4-dioxo-naphthalene derivatives, resulting novel compounds and therapeutical use thereof |
| 06/19/1997 | WO1997021709A1 Use of mono- or diketone tetracyclic derivatives, resulting novel compounds and therapeutical use thereof |
| 06/19/1997 | WO1997021708A1 4-pyrimidinyl- or 4-pyrazinyl-piperazinyl-phenyl-oxazolidinone derivatives, their preparation and their use as anti-bacterial agents |
| 06/19/1997 | WO1997021707A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | WO1997021704A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | WO1997021703A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | WO1997021702A1 3-benzylaminopyrrolidines and -piperidines as tachykinin receptor antagonists |
| 06/19/1997 | WO1997021701A1 Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives |
| 06/19/1997 | WO1997021695A1 4,10β-DIACETOXY-2α-BENZOYLOXY-5β,20-EPOXY-1-HYDROXY-9-OXO-19-NOR-CYCLOPROPA[G]TAX-11-ENE-13α-YL (2R,3S)-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE DIHYDRATE, AND METHOD FOR PREPARING SAME |
| 06/19/1997 | WO1997021692A1 Novel compounds and methods for treating multiple sclerosis |
| 06/19/1997 | WO1997021690A1 D-amino acid derived inhibitors of cysteine and serine proteases |
| 06/19/1997 | WO1997021685A1 Retroviral protease inhibiting compounds |
| 06/19/1997 | WO1997021684A1 Use of tricyclic 1,4-dihydro-1,4-dioxo-1h-naphthalene derivatives, resulting novel compounds and therapeutical use thereof |
| 06/19/1997 | WO1997021683A1 Retroviral protease inhibiting compounds |
| 06/19/1997 | WO1997021682A1 3-pyrazolecarboxamide derivatives having cannabinoid receptor affinity |
| 06/19/1997 | WO1997021680A1 Quinoline derivatives |
| 06/19/1997 | WO1997021676A1 Azetidinone compounds for the treatment of atherosclerosis |
| 06/19/1997 | WO1997021675A1 Monocyclic beta-lactame derivatives for treatment of atherosclerosis |
| 06/19/1997 | WO1997021670A1 New phenylamidine derivatives, a process for preparing the same and their use as medicaments |
| 06/19/1997 | WO1997021668A1 Phenylacetamide derivatives |
| 06/19/1997 | WO1997021665A1 Arylethanolamine derivatives and their use as agonists of atypical beta-adrenoceptors |
| 06/19/1997 | WO1997021664A1 NAPHTHYL ACETAMIDES AS sPLA2 INHIBITORS |
| 06/19/1997 | WO1997021451A1 Anti-cocaine vaccine |
| 06/19/1997 | WO1997021447A1 Compositions and therapeutic methods using morphogenic proteins and stimulatory factors |
| 06/19/1997 | WO1997021445A1 Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis |
| 06/19/1997 | WO1997021441A1 Ophthalmic composition comprising polyoxyethylene-polyoxypropylene polymers |
| 06/19/1997 | WO1997021440A1 A solution for oral administration containing ici 182,780 |
| 06/19/1997 | WO1997021439A1 Medicament intended to the treatment of obsessive compulsive troubles, sleep apnoea, sexual dysfunctions, emesa and transport sickness |
| 06/19/1997 | WO1997021438A1 Method for controlling serum glucose, fatty acids, and blood pressure in non-insulin-dependent diabetic mellitus patients |
| 06/19/1997 | WO1997021437A1 Naphthyl-substituted benzimidazole derivatives as anticoagulants |
| 06/19/1997 | WO1997021436A1 New use for losartan |